Moderna became the latest pharmaceutical company to apply for the US Food and Drug Administration on Tuesday. Full approval for its coronavirus vaccine For use in people 18 and older. FDA approval will allow the company to market the shot directly to consumers, and may also help increase public confidence in the vaccine.
Full approval can also make it easier The schools, Employers, Government agencies, and the US military, which has Resistance to coronavirus vaccines was encountered, To make vaccination compulsory.
“We look forward to working with the FDA and will continue to submit data from our Phase 3 study and to complete rolling submissions,” Stephen Barnell, Chief Executive Officer of Moderna, said in a statement.
last month Pfizer and Bioentech Applied to the agency for full acceptance of its vaccine for use in people 16 and older.
Moderna’s vaccine was Authorized for emergency use In December, and as of Sunday, more than 151 million doses were given in the United States, According to statistics From the Centers for Disease Control and Prevention.
Last week, Moderna announced that its Vaccine appears to be highly effective in adolescents And it plans to apply for the Emergency Use Authority for Adolescents in June. Pfizer’s vaccine was Authorized for use in 12- to 15-year-olds last month.
Both Moderna And Pfizer Vaccines require two shots at intervals of several weeks, and are built around messenger RNA, the genetic material that cells read to make proteins, to help produce antibodies to the virus.
Modarna’s full approval request comes as more than 50 percent of the US population At least one dose of a vaccine has been received, but the speed of vaccination is Dropped sharply from mid-April. A recent survey from Kaiser Family Foundation Indicated that Some hesitating people have been forbidden: About a third of people had planned to “wait and see” whether they would get vaccinated or not, saying they had made vaccine appointments or planned to do so.
“I think there are many people who were on the fence, who were worried about things moving too fast and the possible side effects,” said Dr. William Scheffner, Medical Director of the National Foundation for Infectious Diseases and a vaccine specialist. “But those concerns are being overcome as they watch their friends and acquaintances celebrate vaccination.”
Jan Hoffman contributed reporting.